JP Morgan Chase & Co. JPM is reportedly gauging investor interest in a possible issuance of high-yield bonds by Walgreens Boots Alliance, Inc. WBA, aimed at managing the drug-store chain’s recently downgraded near-term debt obligations.
Preliminary discussions on pricing suggest a yield in the vicinity of 7.5%, reported Bloomberg, citing people familiar with the discussions.
The specific size and duration of the deal have not been finalized. Walgreens currently holds a $1.16 billion note maturing on November 18, trading close to par, and a £300 million ($387 million) bond due in late 2025, as per Bloomberg data.
Should Walgreens proceed with a bond sale, it would mark their first issuance since being downgraded to junk status by both Moody’s Ratings and S&P Global Ratings.
Also Read: Rite Aid Forges Path To Financial Recovery With Major Settlement: Report
This move would entail significantly higher costs, with the highest coupon rate currently at 4.8% on a 2044 bond issued a decade ago.
In January, Walgreens nearly halved its dividend following a CEO change. Meanwhile, Rite Aid Corp RADCQ is in bankruptcy, CVS Health Corporation CVS faces retail challenges, and Walmart Inc. WMT
scrapped plans for low-cost clinics due to cost and reimbursement issues.
S&P’s recent BB downgrade indicates Walgreens’ leverage ratio could remain above five times into fiscal 2025 and beyond, Bloomberg added.
Price Action: WBA shares are trading higher by 2.24% to $11.41 at last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: refrina/Shutterstock.com
Read Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
